Sign in
IUGNF Stock Price, Chart, Stats & News
Imugene Limited
Save
Imugene Limited (IUGNF) does not currently pay a dividend.
–
Market cap
–
Current P/E
–
Forward P/E
IUGNF chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Imugene Limited, an Australian firm specializing in clinical-stage immuno-oncology, is dedicated to conceiving diverse immunotherapies. Its core mission involves activating the immune systems of cancer patients to effectively combat and eradicate malignant growths. The company's primary therapeutic candidate is HER-Vaxx, a vaccine engineered for HER2-positive cancers.
Similar securities
Based on sector and market capitalization
Report issue